Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death

Safety of pancreaticoduodenectomy has improved significantly in the past 3 decades. Current inpatient and 30-d mortality rates are low. However, incidence and causes of 90-d and 1-y mortality are poorly defined and largely unexplored. All patients who had pancreaticoduodenectomy between 2007 and 201...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of surgical research Vol. 231; pp. 304 - 308
Main Authors Narayanan, Sowmya, Martin, Allison N., Turrentine, Florence E., Bauer, Todd W., Adams, Reid B., Zaydfudim, Victor M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2018
Subjects
Online AccessGet full text
ISSN0022-4804
1095-8673
1095-8673
DOI10.1016/j.jss.2018.05.075

Cover

More Information
Summary:Safety of pancreaticoduodenectomy has improved significantly in the past 3 decades. Current inpatient and 30-d mortality rates are low. However, incidence and causes of 90-d and 1-y mortality are poorly defined and largely unexplored. All patients who had pancreaticoduodenectomy between 2007 and 2016 were included in this single institution, retrospective cohort study. Distributions of pancreaticoduodenectomy-specific morbidity and cause-specific mortality were compared between early (within 90 d) and late (91-365 d) postoperative recovery periods. A total of 551 pancreaticoduodenectomies were performed during the study period. Of these, 6 (1.1%), 20 (3.6%), and 91 (16.5%) patients died within 30, 90, and 365 d after pancreaticoduodenectomy, respectively. Causes of early and late mortality varied significantly (all P ≤ 0.032). The most common cause of death within 90 d was due to multisystem organ failure from sepsis or aspiration in 9 (45%) patients, followed by post-pancreatectomy hemorrhage in 5 (25%) patients, and cardiopulmonary arrest from myocardial infarction or pulmonary embolus in 3 (15%) patients. In contrast, recurrent cancer was the most common cause of death in 46 (65%) patients during the late postoperative period between 91 and 365 d. Mortality from failure to thrive and debility was similar between early and late postoperative periods (15% versus 19.7%, P = 0.76). Most quality improvement initiatives in patients selected for pancreaticoduodenectomy have focused on reduction of technical complications and improvement of early postoperative mortality. Further reduction in postoperative mortality after pancreaticoduodenectomy can be achieved by improving patient selection, mitigating postoperative malnutrition, and optimizing preoperative cancer staging and management strategies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Authors’ contributions: Study conception and design were done by S.N., F.E.T., and V.M.Z. Data acquisition was done by S.N. and V.M.Z. Analysis and interpretation of data were done by S.N., A.N.M., F.E.T., T.W.B., R.B.A., and V.M.Z. Drafting of manuscript was done by S.N., A.N.M., and V.M.Z. Critical revision was done by F.E.T., T.W.B., and R.B.A.
ISSN:0022-4804
1095-8673
1095-8673
DOI:10.1016/j.jss.2018.05.075